Immunization for atherosclerosis - PubMed (original) (raw)

Review

Immunization for atherosclerosis

Kuang-Yuh Chyu et al. Curr Atheroscler Rep. 2007 Aug.

Abstract

This review summarizes experimental findings that highlight the complex roles of the immune system in atherogenesis. Immune activation can have either proatherogenic or atheroprotective effects. Immune-modulation therapy via an active or passive immunization strategy aims to exploit the atheroprotective aspects of the immune system to modulate atherosclerosis. Several experimental studies have demonstrated that such an approach is feasible and effective, raising the tantalizing possibility that an atheroprotective vaccine can be developed for clinical testing. Several potential immunogens have been identified and tested for their atheroprotective efficacy with variable results. Although several questions such as choice of optimal antigens, choice of most effective adjuvants, the optimal route of administration, durability of effects, and safety remain to be answered, we believe that a vaccine-based approach to manage atherosclerotic cardiovascular disease is a potentially viable paradigm.

PubMed Disclaimer

References

    1. Atherosclerosis. 2006 Nov;189(1):83-90 - PubMed
    1. J Biol Chem. 2002 Mar 1;277(9):7010-20 - PubMed
    1. Arterioscler Thromb Vasc Biol. 2002 Nov 1;22(11):1892-8 - PubMed
    1. Biochem Biophys Res Commun. 2001 Aug 10;286(1):164-70 - PubMed
    1. J Clin Invest. 1995 Sep;96(3):1389-94 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources